Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: A randomized, placebo-controlled, double-blind and crossover trial

MPG-Autoren
/persons/resource/persons141337

Preckel,  Katrin
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons19764

Kanske,  Philipp
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

/persons/resource/persons20000

Singer,  Tania
Department Social Neuroscience, MPI for Human Cognitive and Brain Sciences, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)

Preckel_Kanske_2016.pdf
(Verlagsversion), 699KB

Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Preckel, K., Kanske, P., Singer, T., Paulus, F. M., & Krach, S. (2016). Clinical trial of modulatory effects of oxytocin treatment on higher-order social cognition in autism spectrum disorder: A randomized, placebo-controlled, double-blind and crossover trial. BMC Psychiatry, 16: 329. doi:10.1186/s12888-016-1036-x.


Zitierlink: https://hdl.handle.net/21.11116/0000-0004-A21A-8
Zusammenfassung
Autism spectrum disorders are neurodevelopmental conditions with severe impairments in social communication and interaction. Pioneering research suggests that oxytocin can improve motivation, cognition and attention to social cues in patients with autism spectrum disorder. The aim of this clinical trial is to characterize basic mechanisms of action of acute oxytocin treatment on neural levels and to relate these to changes in different levels of socio-affective and -cognitive functioning.